How to Approach Zimmer Biomet Procurement: A Buyer’s Guide for Dual Mobility, ROSA, and Diagnostic Equipment

There’s No ‘One Right Way’ to Buy Zimmer Biomet Products – Here’s How to Find Yours

I manage ordering for a mid-size orthopedic surgery center – roughly $1.2M annually across 8 vendors. When I took over purchasing in 2020, I assumed there was a standard playbook for buying from a major manufacturer like Zimmer Biomet. Get three quotes. Compare unit prices. Choose the cheapest. Simple, right?

Not even close. The reality is that what works for a 50-bed community hospital doesn’t work for a 400+ bed academic center. A high-volume joint replacement practice has different needs than a general ortho clinic just starting with robotics. And that’s before you get into the diagnostic equipment debate – which, honestly, still trips me up sometimes.

So instead of pretending there’s a single answer, I’ll walk you through the three most common scenarios I’ve seen (and managed), with specific advice for each. By the end, you’ll know which one fits your situation.

Scenario A: You’re a New Center or Practice Starting from Scratch

If you’re equipping a new surgery center or expanding into orthopedics for the first time, you’ve got a blank slate – and that’s both a blessing and a curse. The blessing: you can design your workflow around the latest tools. The curse: you don’t have existing relationships or volume discounts to rely on.

In this scenario, I’d focus on three things:

• Start with the ROSA platform – if your caseload justifies it. Zimmer Biomet’s ROSA robotics isn’t cheap (think mid-six figures depending on configuration), but the training and support that come with it are significant. Per Zimmer Biomet’s own 2025 surgical technique literature, the learning curve for ROSA-assisted knee replacements is about 15–20 cases. That’s faster than some competitors, and it’s backed by published clinical data.
• Don’t over-buy implants upfront. I’ve seen centers order $50k in dual mobility inventory only to realize their patient mix is 80% standard primary THA (total hip arthroplasty). The Zimmer Biomet dual mobility (like the G7 Dual Mobility) is a great option for high-risk dislocation patients, but it’s not necessary for everyone. Our center uses it in about 15–20% of cases.
• Verify invoicing and logistics before the first order. This is where I learned my lesson the hard way. In 2021, I placed a $38k order for Persona knee implants from a new distributor – great price, handwritten invoice. Finance rejected it. I had to cover the cost from my department budget. Now I verify that every vendor can provide a proper, machine-generated invoice with a PO number before I place a single line item.

Bottom line for Scenario A: Invest in the platform that fits your volume, but don’t stockpile inventory you won’t use in 6 months. And always, always verify the paperwork.

Scenario B: You’re an Established Hospital or Surgery Center Looking to Optimize

If you’ve been buying Zimmer Biomet products for years, your challenge isn’t selection – it’s consolidation and cost efficiency. You probably have 3–5 different contracts, multiple distributors, and a mix of old and new implant systems.

In our 2024 vendor consolidation project, I found that we were paying 22% more for identical dual mobility implants from one distributor vs. another. Same catalog item numbers. Same packaging. Just different contract terms negotiated years apart.

Here’s what I’d prioritize:

• Audit your existing inventory – especially for high-cost items like Zimmer Biomet’s Persona knee components or G7 hip cups. We found $14k in expired or near-expiry implants that we’d over-ordered during the pandemic.
• Re-evaluate your ROSA utilization. If you bought a ROSA Knee system in 2022, are you using it for at least 50% of eligible cases? Industry benchmarks suggest that centers hitting that threshold see a measurable reduction in revision rates and length of stay (Source: Zimmer Biomet 2024 clinical data). If you’re below that, the ROI doesn’t hold up.
• Consider the CBCT vs. panoramic debate for dental integration. If your center also does dental implant procedures (and many ortho centers are expanding into this), the imaging decision matters. A CBCT scan gives you 3D data for implant planning – essential for complex cases. But for routine single-tooth implants, a panoramic radiograph is often sufficient. According to the American Academy of Oral and Maxillofacial Radiology, CBCT radiation dose is 3–10 times higher than panoramic. So unless you’re doing guided surgery or have anatomical concerns, don’t default to CBCT for every case.

Bottom line for Scenario B: Optimize what you already have before buying new. The lowest-hanging fruit is usually contract consolidation, not new equipment.

Scenario C: You’re a Small Practice or Clinic with Limited Budget

This is the toughest scenario. Your volume doesn’t qualify for the best pricing tiers, and you can’t justify a ROSA system or a full CBCT unit. But you still need reliable implants and diagnostic tools.

Here’s where the ‘value over price’ perspective really matters. It’s tempting to buy the cheapest dual mobility option from a secondary distributor. Don’t. I’ve seen this backfire spectacularly.

In 2023, a colleague at a small clinic saved $200 on each of 12 G7 dual mobility cups by buying from an unauthorized reseller. Six months later, three of those patients had complications requiring revision. The total cost? Over $40k in additional surgeries and legal liability. That $200 savings turned into a $1,500 problem – per cup.

For small practices, I recommend:

• Focus on the essentials: A good quality ICU monitor (for same-day surgery recovery) and a class II biosafety cabinet if you’re doing any sterile compounding. These are non-negotiable for safety and compliance. According to NSF/ANSI 49, biosafety cabinets must be certified annually – don’t skip it.
• Lease, don’t buy. Zimmer Biomet offers leasing options for ROSA systems and even some implant inventory. The monthly cost can be $4k–$8k depending on the agreement, which is manageable for a practice doing 50+ joint replacements per year.
• Join a group purchasing organization (GPO). This won’t get you the same pricing as a major hospital, but it can reduce your implant costs by 15–25% compared to buying direct. I’ve used this route, and the savings are real – but only if you actually track and use the contract.

Bottom line for Scenario C: Don’t let budget pressure push you to unsafe shortcuts. Leasing and GPO membership can mitigate the cost gap without compromising quality.

How to Know Which Scenario You’re In

If you’re still unsure, ask yourself three questions:

1. What’s your annual implant volume? Under 100 cases? You’re likely Scenario C. 100–300? Scenario B. Over 300? Scenario A or B, depending on whether you’re expanding or optimizing.
2. Do you already have a ROSA system? If yes, you’re in Scenario B. If no and you’re considering one, you’re in Scenario A or C depending on budget.
3. How much of your caseload is high-risk for dislocation? If >30%, the dual mobility conversation changes. If <10%, it’s a niche tool, not a core inventory item.

That’s the framework I use, and it’s saved me from a few expensive mistakes. Your mileage may vary – but at least now you know which questions to ask.